Pharmacogenetics of alcohol, nicotine and drug addiction treatments. - Wikidata - awgldk - TriplyDB

Pharmacogenetics of alcohol, nicotine and drug addiction treatments.

Pharmacogenetics of alcohol, nicotine and drug addiction treatments.

http://www.wikidata.org/entity/Q37848476

about

Future pharmacological treatments for substance use disorders The relationship of appetitive, reproductive and posterior pituitary hormones to alcoholism and craving in humans The uncanny return of the race concept.Pathways to precision medicine in smoking cessation treatments.Relapse prevention for addictive behaviors Toward personalized smoking-cessation treatment: Using a predictive modeling approach to guide decisions regarding stimulant medication treatment of attention-deficit/hyperactivity disorder (ADHD) in smokers.Unwarranted optimism in media portrayals of genetic research on addiction overshadows critical ethical and social concerns.Biomarkers to optimize the treatment of nicotine dependence.Genetic Similarities between Compulsive Overeating and Addiction Phenotypes: A Case for "Food Addiction"?The opioid receptors as targets for drug abuse medication The genetics of addiction-a translational perspective Opiate addiction and cocaine addiction: underlying molecular neurobiology and genetics.KCNN Genes that Encode Small-Conductance Ca2+-Activated K+ Channels Influence Alcohol and Drug Addiction.The genetics of the opioid system and specific drug addictions Pharmacogenetics in psychiatry: translating research into clinical practice.Association of µ-opioid receptor (OPRM1) gene polymorphism with response to naltrexone in alcohol dependence: a systematic review and meta-analysis.Efficacy and tolerability of baclofen in substance use disorders: a systematic review.Pharmacogenetic approaches in the treatment of alcohol use disorders: addressing clinical utility and implementation thresholds.Neuromodulation interventions for addictive disorders: challenges, promise, and roadmap for future research.Naltrexone ameliorates functional network abnormalities in alcohol-dependent individuals.The role of the endocannabinoid system in addictive behavior.A systems medicine research approach for studying alcohol addiction.Sodium oxybate to treat alcohol dependence: 20 years of clinical experience.Precision medicine and pharmacogenetics: what does oncology have that addiction medicine does not?

P2860

Q22242633-55D038E7-D223-4880-B066-8B2288FC099A Q26992207-977A52FC-6A67-4033-BB18-2844E5620237 Q34448886-9C555650-B618-4BA1-8F25-0EA7223A3BF2 Q34527740-01CE1721-6FB2-4523-BFB3-957419E89C6D Q35184972-BEB9CBDE-4316-4DAB-B502-19966B6AFD30 Q35588731-91A0C1EF-49D2-4ACB-9CCD-A26680D1E970 Q35671471-9EA2F78C-B22C-415C-9ECE-399E88D143B0 Q35773685-7354AFB1-6311-4F6A-BDBD-847C403DFBCA Q35811863-24D5F667-7068-4124-B9AD-72FA492E5FE8 Q35978068-AB01C83A-D751-4D63-A18F-9DBCFEA5030B Q36135947-5FC92EF4-0F80-4E10-80E2-F22E6F7FF0DC Q36499673-38ABBB5E-1F3B-4BE7-9EB7-B643766B0C32 Q36821781-93B67C12-B8D0-48F9-9C6B-F4BCF6F0CBB1 Q37040492-AF8E63EE-13A1-4DA7-B5AD-E0389A20C51C Q37956206-F2666D2C-58E5-46DE-8555-BBABCFE37062 Q38003649-77188D58-5EB3-4EA6-B7E3-818F82443088 Q38115144-F393EF2D-4997-4CFA-8034-E422910363CC Q38248763-80D519FF-8ECB-427A-9E66-EC804B575FE6 Q38771142-B6493DC7-A8BF-4480-B2C4-0FB4A6AAD14F Q38936254-5E22DF57-D97D-4C2E-B654-9A6FA51BFF0E Q44511186-7CE91A01-4E7D-4289-9BEB-C2EBBACD2F10 Q45260924-B9799FAB-E457-4852-B6E2-97B468071330 Q45798267-9DFD88A3-099C-4026-86BA-8DBF94ED601E Q47742671-C8BDB2C3-F13F-4E42-AFFF-0D7EA8F3D8E0

P2860

Pharmacogenetics of alcohol, nicotine and drug addiction treatments.

http://www.wikidata.org/entity/Q37848476

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on March 2011

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Pharmacogenetics of alcohol, nicotine and drug addiction treatments.

@en

Pharmacogenetics of alcohol, nicotine and drug addiction treatments.

@nl

type

label

Pharmacogenetics of alcohol, nicotine and drug addiction treatments.

@en

Pharmacogenetics of alcohol, nicotine and drug addiction treatments.

@nl

prefLabel

Pharmacogenetics of alcohol, nicotine and drug addiction treatments.

@en

Pharmacogenetics of alcohol, nicotine and drug addiction treatments.

@nl

P1433

Q37848476-CCAA723F-92C6-4CA5-8AB6-3ABA63ED7EE6

P1476

Q37848476-D77FE0AC-EA1E-4438-8D40-79D55A5173F0

P2093

Q37848476-4808A962-1644-46F0-B4C9-9703939048FA

Q37848476-5A31F38A-492B-4F9D-995F-26719B5E74D9

Q37848476-99256552-54E6-4CDB-8471-DD8F8285BF2A

Q37848476-DACF64D9-E75F-4FEA-989D-05060A895156

Q37848476-FE3890BF-38D1-4766-9C35-1EC4C4788928

P2860

Q37848476-0029ED89-BF82-46C8-A0FB-DEDE00494D14

Q37848476-00F8DAF7-512A-49E2-B46B-3E5B0A0C9506

Q37848476-029DF1AF-4DF8-4F3F-A8F1-482D8191435A

Q37848476-0391A595-A956-4963-9D9D-3962E10D14B3

Q37848476-03B0BFEB-C5E7-4BA4-B55C-0D93114DFCC8

Q37848476-087E947E-0F20-419E-B9CC-87EBDEDBF64F

Q37848476-08D5156C-3CF2-497A-BD0B-E227B0002278

Q37848476-0A1BD82B-B282-4370-B76B-07478BF1647D

Q37848476-0FA56A41-98E1-4EB6-AF98-21C5729F43DC

Q37848476-1352DF6C-B321-4775-8D7F-32ECF99D88D9

P304

Q37848476-E37DC139-81CB-4894-B0FF-30A4B08B854C

P31

Q37848476-D54CCDC8-7522-4D36-A296-3C4331033AEC

P356

Q37848476-4A8CAE45-A540-403C-BC1A-F943BA55AB02

P433

Q37848476-0DC64F22-FFCB-4BBE-84D0-98E1F82E8107

P478

Q37848476-5976876C-1FBF-4DA0-BBEB-7F74B8DBEB27

P577

Q37848476-6EADC8AA-F110-45E5-9EEF-25BEC632805D

P5875

Q37848476-66413951-1EC0-4E79-8797-0900D6342EB2

P698

Q37848476-989B96D9-E5D1-456D-8DB9-A4BDC9F2FE69

P921

Q37848476-A12E1661-F9A8-4601-A7CC-66FE3D1C9091

P356

J.1369-1600.2010.00287.X

P1433

Addiction Biology

P1476

Pharmacogenetics of alcohol, nicotine and drug addiction treatments.

@en

P2093

Andreas Heinz

http://www.w3.org/2001/XMLSchema#string

Daniel J Müller

http://www.w3.org/2001/XMLSchema#string

James L Kennedy

http://www.w3.org/2001/XMLSchema#string

Jessica E Sturgess

http://www.w3.org/2001/XMLSchema#string

Tony P George

http://www.w3.org/2001/XMLSchema#string

P2860

Effectiveness of smoking cessation therapies: a systematic review and meta-analysis

Actual Causes of Death in the United States, 2000

Single-nucleotide polymorphism in the human mu opioid receptor gene alters beta-endorphin binding and activity: possible implications for opiate addiction

An evaluation of mu-opioid receptor (OPRM1) as a predictor of naltrexone response in the treatment of alcohol dependence: results from the Combined Pharmacotherapies and Behavioral Interventions for Alcohol Dependence (COMBINE) study

Molecular genetics of successful smoking cessation: convergent genome-wide association study results

2-Phenyl-2-(1-hydroxycycloalkyl)ethylamine derivatives: synthesis and antidepressant activity

A quantitative-trait analysis of human plasma-dopamine beta-hydroxylase activity: evidence for a major functional polymorphism at the DBH locus

Nicotine activation of alpha4* receptors: sufficient for reward, tolerance, and sensitization

Acetylcholine receptors containing the beta2 subunit are involved in the reinforcing properties of nicotine

Human neuronal nicotinic receptors.

P304

357-376

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1369-1600.2010.00287.X

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

16

http://www.w3.org/2001/XMLSchema#string

P577

2011-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

50249114

http://www.w3.org/2001/XMLSchema#string

P698

21362114

http://www.w3.org/2001/XMLSchema#string

P921

substance dependence